• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 14.02
  • VXN 16.95
  • VXO 14.44
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)

Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:

Indicator Windows:

Company Profile

Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States. The company?s Ophthalmic segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are used in the office setting. It also sells therapeutic products, such as antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers. In addition, this segment offers non-pharmaceutical products, including various artificial tear solutions, preservative-free lubricating ointments, and eyelid cleansers. The company?s Hospital Drugs & Injectables segment markets hospital drug and injectable pharmaceutical products, including antidotes, anti-infectives, and controlled substances for pain management and anesthesia; and other pharmaceutical products. This segment markets products to hospitals through the wholesale distribution channel. Its Contract Services segment manufactures ophthalmic and injectable pharmaceutical products for third party pharmaceutical customers. The company?s customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, and other pharmaceutical companies. It has strategic partnerships with Strides Arcolab Limited; Serum Institute of India, Ltd.; Hameln Pharmaceuticals; and Cipla, Ltd. The company was founded in 1971 and is headquartered in Lake Forest, Illinois.

AKRX (Akorn Inc)
Last Trade 1.31 Date 1/24/2020
Change % -3.68 % Price Change -0.05
Open 1.35 52 Week High 5.46
High 1.36 52 Week Low 1.19
Low 1.3 Type stock
Volume 1421925 Average Volume 2462471
Prev Close 1.36 Stock Exchange NASDAQ
Bid 1.3 Ask 1.4
Bid Size 40 Ask Size 11
1st Yr Estimated EPS Growth -1.0 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 0.0763 2 Years Forward PE Ratio 13.1
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA 5.8794
Book Value per Share 2.4766 Book Value Yield 1.8905
Buy Back Yield CAPE Ratio 153.096
Cash Return -0.0839 Cash Flow per Share -0.2175
Cash Flow Yield -0.166 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield -2.1985 EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA 6.6381
EV / Forward Revenue 1.126 EV / Pre Tax Income
EV / Revenue 1.2221 EV / Total Asset 0.5886
Expected Dividend Growth Rate Free Cash Flow per Share -0.5487
Free Caash Flow Ratio Free Cash Flow Yield -0.4189
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield 0.0 Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio 0.0
PB Ratio 0.528959 PB Ratio 10 Year Growth -0.179248
PB Ratio 3 Year Growth 2.670482 Cash Ratio 3 Year Average 715.4135
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average 56.152654 PE Ratio 10 Year Growth
PE Ratio 10 Year High 240.25 PE Ratio 10 Year Low 12.401361
PE Ratio 1 Year Avg PE Ratio 1 Year High
PE Ratio 1 Year Low PE Ratio 3 Year Avg 33.162723
PE Ratio 5 Year Avg 63.90295 PE Ratio 5 Year High 240.25
PE Ratio 5 Year Low 12.401361 Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg 23.888552 Price Change 1 Month 0.873333
Price to Cash Ratio 0.803977 Price / EBITDA
Price to Sales Ratio 0.244694 Price to Sales Ratio 10 Year Growth -0.186952
Price to Sales Ratio 3 Year Avg 2.195831 Price to Sales Ratio 5 Year Avg 63.90295
Sale per Share 5.3536 Sales Yield 4.0867
Sustainable Growth Rate -0.7487 Tangible Book Value per Share -1.581
Tangible Book Value per Share 3 year Avg -0.9053 Tangible Book Value per Share 5 year Avg -2.4333
Total Asset per Share 11.0853 Total Yield
Working Capital per Share -3.8206 Working Capital per Share 3 Year Avg 1.5363
Working Capital per Share 5 Year Avg 2.3107 Beta 1.93932